NO179232C - Fremgangsmåte for fremstilling av en tablettkapsel eller kuleinnretning for kontrollert frigjöring av ett eller flere virkestoffer, og en fremgangsmåte for fremstilling av et kapselskall - Google Patents

Fremgangsmåte for fremstilling av en tablettkapsel eller kuleinnretning for kontrollert frigjöring av ett eller flere virkestoffer, og en fremgangsmåte for fremstilling av et kapselskall

Info

Publication number
NO179232C
NO179232C NO893450A NO893450A NO179232C NO 179232 C NO179232 C NO 179232C NO 893450 A NO893450 A NO 893450A NO 893450 A NO893450 A NO 893450A NO 179232 C NO179232 C NO 179232C
Authority
NO
Norway
Prior art keywords
preparation
capsule
controlled release
active substances
ball device
Prior art date
Application number
NO893450A
Other languages
English (en)
Norwegian (no)
Other versions
NO893450L (no
NO179232B (no
NO893450D0 (no
Inventor
John Robert Cardinal
Scott Max Herbig
Richard Wilker Korsmeyer
Jeelin Lo
Kelly Lincoln Smith
Avinash Govind Thombre
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO893450D0 publication Critical patent/NO893450D0/no
Publication of NO893450L publication Critical patent/NO893450L/no
Publication of NO179232B publication Critical patent/NO179232B/no
Publication of NO179232C publication Critical patent/NO179232C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Executing Machine-Instructions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Materials For Medical Uses (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
NO893450A 1988-08-30 1989-08-29 Fremgangsmåte for fremstilling av en tablettkapsel eller kuleinnretning for kontrollert frigjöring av ett eller flere virkestoffer, og en fremgangsmåte for fremstilling av et kapselskall NO179232C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23837188A 1988-08-30 1988-08-30

Publications (4)

Publication Number Publication Date
NO893450D0 NO893450D0 (no) 1989-08-29
NO893450L NO893450L (no) 1990-03-01
NO179232B NO179232B (no) 1996-05-28
NO179232C true NO179232C (no) 1996-09-04

Family

ID=22897578

Family Applications (1)

Application Number Title Priority Date Filing Date
NO893450A NO179232C (no) 1988-08-30 1989-08-29 Fremgangsmåte for fremstilling av en tablettkapsel eller kuleinnretning for kontrollert frigjöring av ett eller flere virkestoffer, og en fremgangsmåte for fremstilling av et kapselskall

Country Status (26)

Country Link
EP (1) EP0357369B1 (cs)
JP (1) JPH07112971B2 (cs)
KR (1) KR920008701B1 (cs)
CN (2) CN1058387C (cs)
AT (1) ATE89162T1 (cs)
AU (1) AU615104B2 (cs)
CA (1) CA1338552C (cs)
CZ (1) CZ277763B6 (cs)
DD (1) DD289466A5 (cs)
DE (1) DE68906488T2 (cs)
DK (1) DK175178B1 (cs)
EG (1) EG19189A (cs)
ES (1) ES2041006T3 (cs)
FI (1) FI102515B1 (cs)
HU (1) HU222245B1 (cs)
IE (1) IE62859B1 (cs)
IL (1) IL91398A (cs)
MX (1) MX173942B (cs)
MY (1) MY104183A (cs)
NO (1) NO179232C (cs)
NZ (1) NZ230470A (cs)
PL (1) PL163079B1 (cs)
PT (1) PT91560B (cs)
RU (2) RU1837873C (cs)
YU (1) YU47422B (cs)
ZA (1) ZA896586B (cs)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
US5876752A (en) * 1990-08-07 1999-03-02 Pfizer Inc. Use of interfacially-polymerized membranes in delivery devices
CA2089738C (en) * 1990-09-28 1997-01-21 Avinash Govind Thombre Dispensing device containing a hydrophobic medium
ZA933725B (en) * 1992-05-28 1993-12-15 Elan Corp Plc Tablet formulation
TW235239B (cs) * 1992-11-20 1994-12-01 Pfizer
CA2150019C (en) * 1992-11-30 1999-01-05 Scott M. Herbig Supported liquid membrane delivery devices
US5358502A (en) * 1993-02-25 1994-10-25 Pfizer Inc PH-triggered osmotic bursting delivery devices
NZ283160A (en) * 1994-05-06 1998-07-28 Pfizer Azithromycin in a controlled release dosage form for treating microbiol infections
US5798119A (en) * 1995-06-13 1998-08-25 S. C. Johnson & Son, Inc. Osmotic-delivery devices having vapor-permeable coatings
EP0811374A1 (en) 1996-05-29 1997-12-10 Pfizer Inc. Combination dosage form comprising cetirizine and pseudoephedrine
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
SK180499A3 (en) 1997-07-01 2001-08-06 Pfizer Sertraline salts and sustained-release dosage forms of sertraline
BR9809895A (pt) * 1997-07-01 2000-08-01 Pfizer Prod Inc Formas de dosagem da sertralina de liberação retardada
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
EA007610B1 (ru) * 1998-11-12 2006-12-29 Смитклайн Бичам Плс Таблетка с энтеропокрытием, обеспечивающая отсроченное высвобождение
US6056976A (en) * 1998-11-12 2000-05-02 Leiras Oy Elastomer, its preparation and use
RU2153930C1 (ru) * 1999-02-02 2000-08-10 ООО Научно-исследовательская фирма "Ультрасан" Сорбционная система с регулируемой десорбцией
AU4709000A (en) * 1999-05-17 2000-12-05 Dow Chemical Company, The Process for making cellulose ether capsules with organic acids
GB9923045D0 (en) * 1999-09-29 1999-12-01 Novartis Ag New oral formulations
US20030175349A1 (en) * 2001-01-30 2003-09-18 Council Of Scientific And Industrial Research Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
CN100335041C (zh) 2002-04-04 2007-09-05 辉瑞产品公司 美味咀嚼片剂
US20040043067A1 (en) * 2002-06-19 2004-03-04 Salamone Joseph C. Fluorosiloxane matrix controlled diffusion drug delivery systems
SI1524981T1 (sl) * 2002-07-29 2009-08-31 Glaxo Group Ltd Glaxo Wellcome Formulacije z zadrĺ˝anim sproĺ äśanjem, ki vsebujejo lamotrigin
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US7611728B2 (en) * 2003-09-05 2009-11-03 Supernus Pharmaceuticals, Inc. Osmotic delivery of therapeutic compounds by solubility enhancement
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ589750A (en) 2004-10-21 2012-07-27 Aptalis Pharmatech Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
CN101291652A (zh) * 2005-06-29 2008-10-22 阿尔扎公司 对渗透剂型提供降低的干燥时间的半渗透性组合物
CN101583620B (zh) 2005-11-28 2016-08-17 马里纳斯医药公司 加奈索酮组合物及其制备和使用方法
AU2007242526A1 (en) * 2006-04-24 2007-11-01 Pfizer Products Inc. Asymmetric membranes for drug delivery devices
EP2248541B1 (de) 2009-05-07 2018-10-31 Biotronik Ag Medikamentenbeschichteter ballonkatheter und verfahren zur herstellung desselben
CN101773484B (zh) * 2009-05-12 2013-12-25 沈阳药科大学 胃漂浮渗透泵型非匀质膜胶囊缓控释系统及其制备方法
WO2011039686A1 (en) 2009-09-30 2011-04-07 Pfizer Inc. Latrepirdine oral sustained release dosage forms
SG10201407965XA (en) 2009-12-02 2015-02-27 Aptalis Pharma Ltd Fexofenadine microcapsules and compositions containing them
US10898865B2 (en) * 2013-01-31 2021-01-26 American University In Cairo (AUC) Polymer-carbon nanotube nanocomposite porous membranes
JP6041823B2 (ja) 2013-03-16 2016-12-14 ファイザー・インク トファシチニブの経口持続放出剤形
WO2021014360A1 (en) 2019-07-23 2021-01-28 Pfizer Inc. Oral modified release dosage forms
CA3161153A1 (en) 2019-11-14 2021-05-20 Pfizer Inc. 1-(((2s,3s,4s)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl)methoxy)-7-methoxyisoquinoline-6-carboxamide combinations and oral dosage forms
AU2021217209A1 (en) 2020-02-03 2022-09-29 Kenvue Brands Llc A single layer chewable tablet comprising cetirizine
CN117752838A (zh) * 2023-12-14 2024-03-26 上海应用技术大学 一种摩擦释香微胶囊及方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL271831A (cs) * 1960-11-29
ATE10582T1 (de) * 1981-01-22 1984-12-15 Capsugel A.G. Verfahren zur herstellung pharmazeutischer, darmloeslicher kapseln.
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
GB8322007D0 (en) * 1983-08-16 1983-09-21 Wellcome Found Pharmaceutical delivery system
US4684524A (en) * 1984-03-19 1987-08-04 Alza Corporation Rate controlled dispenser for administering beneficial agent
CA1239034A (en) * 1984-08-17 1988-07-12 Kelly L. Smith Delivery system
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy

Also Published As

Publication number Publication date
PL163079B1 (pl) 1994-02-28
MY104183A (en) 1994-02-28
MX173942B (es) 1994-04-11
IE62859B1 (en) 1995-03-08
IL91398A (en) 1994-05-30
AU615104B2 (en) 1991-09-19
EP0357369A3 (en) 1991-10-02
KR920008701B1 (ko) 1992-10-08
CN1125573A (zh) 1996-07-03
ATE89162T1 (de) 1993-05-15
EG19189A (en) 1994-11-30
KR900002821A (ko) 1990-03-23
YU165789A (en) 1992-05-28
CZ277763B6 (en) 1993-04-14
DK175178B1 (da) 2004-06-28
FI102515B (fi) 1998-12-31
DK424489A (da) 1990-03-01
DD289466A5 (de) 1991-05-02
CS501189A3 (en) 1992-12-16
DK424489D0 (da) 1989-08-29
JPH07112971B2 (ja) 1995-12-06
YU47422B (sh) 1995-03-27
HU222245B1 (hu) 2003-05-28
RU2093147C1 (ru) 1997-10-20
NO893450L (no) 1990-03-01
EP0357369A2 (en) 1990-03-07
EP0357369B1 (en) 1993-05-12
CN1058387C (zh) 2000-11-15
RU1837873C (ru) 1993-08-30
IL91398A0 (en) 1990-04-29
NZ230470A (en) 1991-06-25
DE68906488T2 (de) 1993-09-09
AU4089189A (en) 1990-05-31
NO179232B (no) 1996-05-28
ZA896586B (en) 1991-04-24
NO893450D0 (no) 1989-08-29
CA1338552C (en) 1996-08-27
DE68906488D1 (de) 1993-06-17
IE892771L (en) 1990-02-28
ES2041006T3 (es) 1993-11-01
FI894046A0 (fi) 1989-08-29
HUT74086A (en) 1996-11-28
JPH02174713A (ja) 1990-07-06
CN1042072A (zh) 1990-05-16
PT91560B (pt) 1995-05-04
FI894046L (fi) 1990-03-01
FI102515B1 (fi) 1998-12-31
PT91560A (pt) 1990-03-30

Similar Documents

Publication Publication Date Title
NO179232C (no) Fremgangsmåte for fremstilling av en tablettkapsel eller kuleinnretning for kontrollert frigjöring av ett eller flere virkestoffer, og en fremgangsmåte for fremstilling av et kapselskall
IE830572L (en) Osmotic drug delivery system
ES2001897A6 (es) Procedimiento para la fabricacion de una tableta de liberacion controlada
NO883837L (no) Anordning til avgivelse av et middel i et foerste tidsrom etterfulgt av et andre, lengre tidsrom.
NL168878C (nl) Werkwijze voor de bereiding van een stabiel, actieve zuurstof leverend, vloeibaar concentraat.
DE68911003D1 (de) Verteiler für eine pulverförmige Medikation.
DK457282A (da) Enteriske mikrokapsler og fremgangsmaade til fremstilling deraf
DK0489647T3 (da) N,O-sulfaterede heparosaner, fremgangsmåde til fremstilling heraf og lægemidler indeholdende disse forbindelser.
FI870672A0 (fi) Substituerade tienoimidazolderivat, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska produkter och deras anvaendning som magsyrasekretionshaemmande aemne.
NO154302C (no) Fremgangsmaate og innretning til uttak av flate produkter, fortrinnsvis trykksaker, som er viklet paa en viklekjerne.
NO880848D0 (no) Dehydratiseringsinnretning med behersket vannabsorbsjon.
IT8219833A0 (it) Matrice polimerica di diffusione per la somministrazione di farmaci.
ES2021579B3 (es) Capsulas divisibles en piezas
ES2022515B3 (es) Mezclas de sustancias granuladas para la preparacion de soluciones de dialisis. procedimiento para su preparacion. dispositivo para su realizacion.
NO170124C (no) Fremgangsmaate for fremstilling av en farmasoeytisk kompresjonsgradienttablett inneholdende d-pseudoefedrin
DE3854416D1 (de) Breitbandiger, sehr schneller Videoverstärker.
DE3772954D1 (de) Arzneimittel mit verzoegerter wirkstoffabgabe.
ES517977A0 (es) Procedimiento para la preparacion de una solucion que contiene glucosa y fructosa.
FI883738A0 (fi) Substituerade tienoimidazolderivat, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska produkter och deras anvaendning som magsyrasekret haemmande medel.
JPS5281078A (en) Permeable membrane module
JPS53124610A (en) Dialysate
JPS51131905A (en) Constant volume liquid diaphragm pump
IT8224871A0 (it) Sistema per la somministrazione di medicamenti, programmabile e trapiantabile.
ATE31313T1 (de) 13alpha-alkylgonane, deren herstellung und diese enthaltende pharmazeutische praeparate.
ATE11766T1 (de) Tetra-substituierte benzolderivate, deren herstellung und pharmazeutische praeparate damit.